Jyothy Labs has informed that the Board of Directors of the Company at its meeting held today at 9:30 am and concluded at 10:50 am, approved the Un-audited Financial Results on Standalone and Consolidated basis for the quarter ended June 30, 2023 with Limited Review by the Statutory Auditors of the Company. Accordingly, in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it enclosed a copy of the Un-audited Financial Results on Standalone and consolidated basis for the quarter ended June 30, 2023 accompanied with the Limited Review Report by the Statutory Auditors of the Company.
The above information is a part of company’s filings submitted to BSE.